Definitive Contract 75F40120C00200
Award Date
9/22/20
Potential Completion Date
9/29/25
Potential Value
$2.2M
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $1,000,000.00 definitive contract to the Regents of the University of Michigan to conduct research on the "Influence of Raw Materials Manufacturing Variables and Storage Conditions on Release Performance of Long Acting Release Microsphere Products." This is a cost-no-fee contract with a completion date of September 29, 2019. The University of Michigan is a U.S. Government Entity providing educational services and has extensive...
The Department of Health and Human Services Food and Drug Administration awarded a definitive cost-no-fee contract to the Regents of the University of Michigan for $1,482,306.00. The contract is to conduct research on the influence of raw materials, manufacturing variables, and storage conditions on the release performance of long-acting release microsphere products. The contract does not have a set-aside designation. The University of Michigan is a U.S. state government educational...
This is a federal contract award from the Food and Drug Administration (FDA) to the Regents of the University of Michigan (University of Michigan) for the development of a "Wireless Pharmaceutical Analysis Device (WPAD) and Computational Model to Determine In Vivo Drug Dissolution in GI Tract for Distinguishing Meaningful Product Differences and Ensuring Bioequivalence." The contract is a definitive contract with a cost-no-fee pricing type and has a ceiling value of $6,343,667.39....
This $7,369,588 federal contract was awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan. The contract is titled "In Vivo Predictive Dissolution (IPD) to Advance Oral Product Bioequivalence (BE) Regulation" and aims to develop improved methods for assessing the bioequivalence of oral drug products. The contract has three main objectives: 1) Mass transport analysis of the gastrointestinal tract, 2) Development and validation of gastrointestinal...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,151,037 firm-fixed-price contract to the Regents of the University of Michigan for the development of "SEAMLESS DESIGN FOR MULTICOMPONENT ENDPOINTS FOR DRUG DEVELOPMENT IN RARE DISEASES." This definitive contract, which has a completion date of September 29, 2026, does not have a set-aside designation. The University of Michigan, a prominent U.S. state government-owned educational...
This federal contract, awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan, is a $2,235,290.00 firm fixed-price definitive contract to conduct a comprehensive study on stimulant and opioid use and use disorder trajectories and associated consequences in U.S. adults. The contract does not have a set-aside designation. The University of Michigan, as the prime contractor, will leverage its extensive research capabilities to carry out this study. Two...
This federal contract award was issued by the National Heart Lung and Blood Institute, a civilian agency, to the Regents of the University of Michigan to conduct a Phase 1 study assessing the safety and pharmacokinetics of the drug candidate GMI-1271 in healthy adult subjects and calf vein DVT. The contract is a definitive contract with a cost-no-fee pricing type and has a ceiling value of $1,364,883.82. The contract was awarded on November 14, 2013 with an ultimate completion date of November...
The U.S. National Cancer Institute awarded a firm fixed-price purchase order contract worth $21,672.38 to the Regents of the University of Michigan for laboratory testing services. The contract has a period of performance through December 29, 2025. The University of Michigan is a U.S. government entity and one of the top public research universities, with a history of providing research and development services to federal agencies like the Department of Defense and NASA under past prime and...
This federal contract award was issued by the Veterans Integrated Service Network 10, a civilian agency within the Department of Veterans Affairs (VA), to the Regents of the University of Michigan, doing business as the University of Michigan. The contract is for $192,834.27 in laboratory testing and consultation services, with a firm fixed-price delivery order of $146,771 and a period of performance ending on November 30, 2021. The award does not appear to have a set-aside designation. The...
This is a $132,528.15 firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the Regents of the University of Michigan to provide transcriptomic evaluations of kidney tissue. The contract has no set-aside designation and will be performed in Ann Arbor, Michigan, with a completion date of July 31, 2023. The contract was awarded on August 1, 2022 and originated from a July 2022 solicitation seeking...